The Illness Management and Recovery (IMR) Scale<\/strong> is a standardized, multidimensional psychometric instrument developed by Kim T. Mueser<\/a> and colleagues in 2004 at the New Hampshire-Dartmouth Psychiatric Research Center. Created to evaluate outcomes within the evidence-based Illness Management and Recovery program, the scale measures an individual’s self-management of severe mental illness (such as schizophrenia<\/a>, schizoaffective disorder<\/a>, and bipolar disorder<\/a>) alongside their personal trajectory of psychiatric recovery. The instrument exists in two parallel versions: a 15-item Client Self-Rating version and a corresponding 15-item Clinician Rating version. Each item targets a specific behavioral, cognitive, or functional facet of recovery and illness management\u2014including personal goal progression, psychiatric knowledge, social network involvement, structured role functioning, symptom distress, impairment, relapse prevention, coping efficacy, self-help engagement, medication adherence, and substance-related interference. Every item utilizes a distinct, clinically anchored 5-point Likert-type scale<\/a> (ranging from 1 to 5), yielding a total composite score (ranging from 15 to 75) where higher values signify superior self-management and advanced recovery. Confirmatory and exploratory factor analyses across diverse international samples have consistently revealed a robust multidimensional architecture, typically comprising three primary factors: Recovery<\/em>, Illness Management<\/em>, and Substance Use<\/em>. Psychometric investigations document adequate to high internal consistency (Cronbach’s alpha ranging from .72 to .87 for total scores), strong test-retest stability (intraclass correlation coefficients between .70 and .89), solid convergent validity with validated recovery and quality-of-life instruments, and significant sensitivity to clinical change following structured psychosocial interventions.<\/p>\n Illness Management and Recovery Scale, IMR, psychiatric rehabilitation, severe mental illness, recovery-oriented care, psychometrics, self-management, psychiatric outcome measurement, schizophrenia, relapse prevention<\/p>\n The Illness Management and Recovery (IMR) Scales were developed in 2004 by a multidisciplinary team of psychiatric rehabilitation researchers and clinicians affiliated with the New Hampshire-Dartmouth Psychiatric Research Center (Concord, NH) and the Substance Abuse and Mental Health Services Administration (SAMHSA<\/a>):<\/p>\n The Illness Management and Recovery (IMR) Scale was specifically designed to bridge a critical methodological gap in psychiatric rehabilitation: the absence of a brief, standardized, dual-perspective outcome instrument capable of capturing both objective behavioral indicators of illness self-regulation and subjective dimensions of personal recovery. During the early 2000s, mental health policy and service delivery models shifted dramatically from symptom suppression and maintenance toward a recovery-oriented paradigm. Concurrently, the Substance Abuse and Mental Health Services Administration (SAMHSA) commissioned the National Evidence-Based Practices Project, which identified illness self-management as an essential psychosocial intervention for individuals diagnosed with severe mental illnesses (SMI). The IMR curriculum was packaged as a comprehensive, structured psychosocial intervention consisting of psychoeducation, behavioral tailoring for medication adherence, relapse prevention planning, social skills training, and cognitive-behavioral strategies for persistent symptoms.<\/p>\n To assess fidelity, monitor longitudinal progress, and evaluate therapeutic efficacy, Mueser and colleagues devised the IMR Scales. The primary clinical and research objectives of the instrument encompass:<\/p>\n The psychological construct evaluated by the IMR Scale is illness self-management and personal recovery<\/em> in severe mental illness. Rather than framing recovery purely as clinical remission or the absence of psychopathology, the IMR construct conceptualizes recovery as a multidimensional, ongoing personal process of living a meaningful, self-directed life while actively managing psychiatric symptoms and mitigating the disruptive consequences of emotional disorders.<\/p>\n The construct integrates cognitive, behavioral, affective, and systemic-social domains, operationalized across several interrelated facets:<\/p>\n The theoretical framework underpinning the Illness Management and Recovery Scale synthesizes four foundational paradigms within behavioral science and contemporary psychiatric rehabilitation: the Stress-Vulnerability-Coping Model<\/strong>, Albert Bandura’s Social Cognitive Theory<\/a>, the Transtheoretical Model of Health Behavior Change<\/strong>, and the Empowerment \/ Recovery Model<\/strong>.<\/p>\n Originally formulated by Joseph Zubin<\/a> and Bonnie Spring (1977) and later elaborated by Robert Liberman and colleagues (1984), this model posits that the clinical course of severe psychiatric disorders is governed by a dynamic interaction among biological vulnerability (genetic, neurodevelopmental factors), environmental stressors (life events, socio-economic challenges), and protective factors (coping competencies, social support, medication). The IMR Scale operationalizes these protective factors directly: enhancing psychiatric knowledge, acquiring structured relapse prevention plans, engaging social supports, and maintaining treatment adherence systematically attenuate the psychophysiological impact of ambient stress, thereby minimizing clinical exacerbations.<\/p>\n Bandura (1986, 1997) demonstrated that human agency and behavioral execution are fundamentally mediated by perceived self-efficacy<\/em>\u2014an individual’s confidence in their ability to execute the courses of action required to manage prospective situations. The IMR Scale treats illness self-management not as a passive compliance construct, but as an active acquisition of self-regulatory skills. When individuals acquire knowledge, experience mastery in small goal-oriented increments (Item 1), practice cognitive-behavioral coping (Item 11), and observe peer modeling in mutual-help organizations (Item 12), their self-efficacy beliefs increase, leading to superior emotional regulation and sustained behavioral tenacity.<\/p>\n Developed by Prochaska and DiClemente (1983), the Transtheoretical Model conceptualizes health-related behavior change as progression across distinct cognitive and motivational phases: precontemplation, contemplation, preparation, action, and maintenance. The behavioral response anchors across the IMR items reflect this progression. For instance, Item 8 (Relapse Prevention Planning) grades an individual from precontemplative non-awareness (“I don\u2019t know how to prevent relapses”), through contemplation and preparation (“I know 1 or 2 things I can do, but I don\u2019t have a written plan”), to active maintenance and collaborative action (“I have a written plan that I have shared with others”).<\/p>\n Departing from the historical deficit-oriented medical model, the psychiatric recovery paradigm (Anthony, 1993; Deegan, 1988) emphasizes subjective purpose, personal meaning, civic participation, and autonomy regardless of ongoing psychiatric symptoms. The IMR Scale mirrors this paradigm by measuring engagement in normal societal roles (employment, education, parenting) and self-determined personal goals, affirming that recovery is not identical to biological cure.<\/p>\n The psychometric validity of both the Client Self-Rating and Clinician Rating versions of the IMR Scale has been rigorously evaluated in numerous clinical trials and observational studies across diverse cultural and national cohorts.<\/p>\n Convergent validity has been established by correlating IMR scores with established psychometric instruments measuring overlapping psychological constructs:<\/p>\n The scale discriminates effectively between distinct clinical subgroups. In validation studies, patients in acute inpatient psychiatric crisis demonstrated significantly lower IMR composite scores ($M \\approx 42.1, SD = 8.4$<\/span>) compared to stabilized community mental health outpatients participating in maintenance recovery programs ($M approx 56.8, SD = 7.9; t(182) = 11.4, p<\/span> < .001$). Furthermore, the substance-specific items (Items 14 and 15) reliably distinguish between individuals with and without verified dual diagnoses (co-occurring substance use disorders) on standardized diagnostic schedules.<\/p>\n Longitudinal randomized controlled trials (RCTs) assessing the IMR intervention (e.g., Salyers et al., 2010; F\u00e4rdig et al., 2011; Levitt et al., 2009) have documented that baseline and interval IMR scores prospectively predict psychiatric rehospitalization rates. Patients scoring higher on the total IMR scale and specifically on Item 8 (relapse prevention) and Item 13 (medication adherence) demonstrated significantly fewer emergency room visits and hospital readmissions over 12-month follow-up horizons ($Odds Ratio = 0.74, p<\/span> < .05$).<\/p>\n Studies examining concordance between the client self-rating and clinician rating (e.g., Hasson-Ohayon et al., 2007; Salyers et al., 2007) yield moderate, statistically significant bivariate correlations ($r = .35$<\/span> to $.60, p < .001$). Concordance is typically highest on objective, observable behaviors\u2014such as time in structured roles, psychiatric hospitalizations, and medication compliance\u2014and slightly lower on internal, subjective experiences, such as symptom distress and perceived coping efficacy, confirming the additive clinical utility of administering both versions.<\/p>\n The IMR Scale has demonstrated robust reliability parameters across varied clinical settings, languages, and study designs.<\/p>\n Estimates of internal consistency via Cronbach’s alpha<\/a> for the overall 15-item scale indicate acceptable to good reliability:<\/p>\n Test-retest reliability has been evaluated over intervals ranging from one to four weeks among clinically stable outpatients:<\/p>\n When evaluated among independent mental health clinicians assessing the same client using clinical records and structured interview data, the Clinician Rating version exhibits substantial inter-rater agreement, with reported ICCs exceeding $.80$<\/span> across subscales.<\/p>\n The latent dimensionality of the IMR Scale has been investigated using both Exploratory Factor Analysis (EFA)<\/a> and Confirmatory Factor Analysis (CFA)<\/a> across several large international cohorts (e.g., United States, Israel, Sweden, the Netherlands, and Japan).<\/p>\n Although initially conceived as a single composite index of illness management and recovery, empirical factor analyses frequently reject a strictly unidimensional model in favor of three-factor or four-factor oblique structures:<\/p>\n The most widely replicated structure across both client and clinician versions decomposes the 15 items into three correlated domains:<\/p>\n In CFA studies evaluating the three-factor oblique model (e.g., Salyers et al., 2007; F\u00e4rdig et al., 2011; Sklar et al., 2012), goodness-of-fit statistics consistently surpass conventional psychometric thresholds:<\/p>\n Comparative model testing has repeatedly demonstrated that this three-factor configuration provides a substantially superior fit compared to a single-factor unidimensional model (where CFI often falls below $.80$<\/span> and RMSEA exceeds $.09$<\/span>), highlighting that recovery and illness self-management constitute related but distinct dimensions of psychiatric outcomes.<\/p>\n The structural characteristics, administrative guidelines, and scoring mechanisms of the instrument are detailed below:<\/p>\n The Illness Management and Recovery (IMR) Scales were published in 2004<\/strong> by Kim T. Mueser, Susan Gingerich, Michelle P. Salyers, Angela B. McGuire, R. U. Reyes, and H. Cunningham at the New Hampshire-Dartmouth Psychiatric Research Center in collaboration with SAMHSA. <\/p>\n Licensing and Accessibility:<\/strong> The scale is in the public domain<\/strong> as part of the federally sponsored Substance Abuse and Mental Health Services Administration (SAMHSA) Evidence-Based Practices (EBP) KIT series. It may be utilized, reproduced, translated, and administered for clinical, educational, non-profit, and research purposes free of charge without formal royalty fees. Researchers and clinical directors intending to employ the instrument in programmatic evaluations or academic studies are encouraged to cite the original development team and consult the publicly accessible toolkits distributed via SAMHSA and affiliated academic centers.<\/p>\nKeywords<\/h2>\n
Authors<\/h2>\n
\n
Purpose<\/h2>\n
\n
Psychological Construct<\/h2>\n
\n
Theoretical Framework<\/h2>\n
The Stress-Vulnerability-Coping Model<\/h3>\n
Bandura’s Social Cognitive Theory and Self-Efficacy<\/h3>\n
The Transtheoretical Model (Stages of Change)<\/h3>\n
The Consumer Empowerment and Recovery Paradigm<\/h3>\n
Validity<\/h2>\n
Convergent and Concurrent Validity<\/h3>\n
\n
Discriminant Validity<\/h3>\n
Predictive and Longitudinal Criterion Validity<\/h3>\n
Client-Clinician Concordance<\/h3>\n
Reliability<\/h2>\n
Internal Consistency<\/h3>\n
\n
Test-Retest Stability<\/h3>\n
\n
Inter-Rater Reliability<\/h3>\n
Factor Analysis<\/h2>\n
Empirical Factor Solutions<\/h3>\n
The Canonical Three-Factor Model (Salyers et al., 2007; Hasson-Ohayon et al., 2007)<\/h4>\n
\n
Confirmatory Model Fit Indices<\/h3>\n
\n
Instrument \/ Measurement Tool<\/h2>\n
\n
\n
\n
Permissions & Fee and Test Year<\/h2>\n
References<\/h2>\n
\n
13. Items of the Scale (Questionnaire)<\/h2>\n